Radiation maculopathy complicated by intraretinal neovascularization treated with intravitreal bevacizumab.
The purpose of this study was to describe a case of radiation maculopathy as a result of intraretinal neovascularization, treated with intravitreal bevacizumab. This is an interventional case report. A 51-year-old man was treated with radiotherapy and chemotherapy for nasopharyngeal carcinoma. He developed radiation maculopathy associated with intraretinal neovascularization in the left eye. He underwent a course of 3 intravitreal injections of bevacizumab (1.25 mg/0.05 mL). The visual acuity in the left eye improved with complete closure of the intraretinal neovascularization and no recurrence 17 months after the last bevacizumab injection. This case of radiation-induced intraretinal neovascularization responded well to bevacizumab treatment. These lesions may respond more favorably if treated earlier.